Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LSD Dose-Response and Ketanserin Blockade
NCT03321136Phase 1Completed
- Sponsor
- University Hospital Basel
- Start
- Nov 2017
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Lysergide (6 arms), sponsored by University Hospital Basel. Primary endpoint: Altered states of consciousness at 18 months. Started Nov 2017; status: completed.
02
Drugs
Lysergide
Beyond the preview
Go deeper on NCT03321136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03321136.